Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Second Line Treatment of Knee Osteochondral Lesion With Decellularized Treated Osteochondral Allograft. Phase IIa Trial

NCT02430558 is registered in ClinicalTrials.gov with TBF Genie Tissulaire as lead sponsor.

NCT NCT02430558
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02430558 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Second Line Treatment of Knee Osteochondral Lesion With Decellularized Treated Osteochondral Allograft. Phase IIa Trial
Lead sponsor
TBF Genie Tissulaire
Phase
Phase 1/2
Overall status
Terminated
Start date
April 5, 2016
Completion date
June 15, 2021
Enrollment
10 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cartilage injury